Hot Features
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Led by Co-Founder Jon McNeill – co-founder of DVx Ventures and former President of Tesla – and CEO Adam Patti – Former Founder and CEO of IndexIQ Focused on solving the major issues with existing...
CALGARY, Alberta, June 18, 2010 (GLOBE NEWSWIRE) -- Skymark Research, a leading provider of small- and micro-cap independent investment research, today initiated coverage on Antares Pharma, Inc...
BOCA RATON, Fla., March 16 /PRNewswire/ -- Dawson James Securities, a full-service investment firm covering the healthcare and biotechnology industry, issued an upgrade report raising their...
American Stock Exchange Lists Common Stock of Antares Pharma, Inc. NEW YORK, Sept. 23 /PRNewswire/ -- The American Stock Exchange(R) (Amex(R)) today listed the common stock of Antares Pharma...
Antares Pharma's (OTCBB: ANTR / Amex: AIS as of September 23, 2004) North American Licensee BioSante Pharmaceuticals, Inc. Announces Positive Results of Phase II Study of LibiGel(TM), Topical...
RNS Number:2878U Alternative Invest. Strategies Ld 15 January 2004 The unaudited net asset value per ordinary and redeemable ordinary share of the Alternative Investment Strategies Limited...
RNS Number:6615T Alternative Invest. Strategies Ld 24 December 2003 SCHEDULE 10 NOTIFICATION OF MAJOR INTERESTS IN SHARES 1) Name of company Alternative Investment Strategies...
RNS Number:4980T Alternative Invest. Strategies Ld 19 December 2003 ALTERNATIVE INVESTMENT STRATEGIES LIMITED PRELIMINARY ANNOUNCEMENT OF THE FINAL RESULTS The Directors announce...
RNS Number:2205T Alternative Invest. Strategies Ld 12 December 2003 The unaudited net asset value per ordinary and redeemable ordinary share of the Alternative Investment Strategies Limited...
RNS Number:8768S Alternative Invest. Strategies Ld 04 December 2003 SCHEDULE 10 NOTIFICATION OF MAJOR INTERESTS IN SHARES 1) Name of company Alternative Investment Strategies...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 1.62 | 1.62 | 1.62 | 0 | 0 | SP |
| 4 | 0 | 0 | 1.62 | 1.62 | 1.62 | 0 | 0 | SP |
| 12 | 0 | 0 | 1.62 | 1.62 | 1.62 | 0 | 0 | SP |
| 26 | 0 | 0 | 1.62 | 1.62 | 1.62 | 0 | 0 | SP |
| 52 | 0 | 0 | 1.62 | 1.62 | 1.62 | 0 | 0 | SP |
| 156 | 0 | 0 | 1.62 | 1.62 | 1.62 | 0 | 0 | SP |
| 260 | 0 | 0 | 1.62 | 1.62 | 1.62 | 0 | 0 | SP |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
